Aurora Spine has launched Aurora Biologics, a new division dedicated to advancing spinal fusion access through biologic innovation.

Establishing this division creates synergy across the company’s growing spine ecosystem. This includes its interspinous, lumbar, and sacroiliac fusion systems. These mechanical and regenerative technologies now merge in one platform.

The company launched a complete suite of allograft solutions. Turbo Fuse fiber putty is a bone graft substitute made of demineralized bone fibers that increase surface area and promote cellular attachment.

Osteo Graft DBM putty is a demineralized cortical bone graft with a cohesive, moldable consistency to support bone formation without synthetic carriers. Osteo Bridge sponge strips are a sponge-like bone graft substitute that conforms to anatomy and fills bone voids to support structural regeneration.

Each biologic is formulated from 100% allograft bone, free of synthetic carriers. The materials were engineered to fill bony defects or augment fusion sites, providing a natural biologic scaffold for bone regeneration.

“Aurora Biologics completes our strategy of providing customers with a seamless, fully integrated portfolio,” said Mathew Goldstone, chief commercial officer of Aurora Spine. “Each of our mechanical fusion systems—whether lumbar, SI, or cervical—is designed to promote bone growth. With the addition of Aurora Biologics, we now enhance the healing phase as well, allowing surgeons to deliver a fully optimized fusion procedure from start to finish.”

“Our new Aurora Biologics platform not only reinforces our commitment to improved clinical outcomes but also serves as a strong growth catalyst,” added Trent J. Northcutt, president and CEO of Aurora Spine. “By integrating biologics across our minimally invasive product portfolio, we anticipate more than a 30 percent increase over prior biologic offerings—driving stronger margins and creating a powerful new profit engine for Aurora Spine.”

Last month, the company launched its DEXA-L anterior lumbar interbody fusion (ALIF) device, and the product was implanted in initial surgeries.